These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4590986)

  • 1. [Immunogenic properties of Shigella sonnei neurotoxin].
    Kamzolkina NB
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):71-5. PubMed ID: 4590986
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin.
    Kowalewska D; Mulczyk M
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):99-102. PubMed ID: 4613143
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of the synergistic action of enterotoxin on the specific protective complex of Shigella sonnei].
    Korneeva SA; Kovalevskaia IL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):38-41. PubMed ID: 1789032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of the keratoconjunctival model in guinea pigs for quantitative assessment of the immunogenicity of dysentery antigens].
    Korneeva SA; Solov'eva OG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):139-40. PubMed ID: 335731
    [No Abstract]   [Full Text] [Related]  

  • 7. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. I. IMMUNE PHENOMENON AND ANTIBODY FORMATION.
    LIN FC; YANG TL; YEH SH
    Chin Med J; 1964 Jul; 83():454-62. PubMed ID: 14191218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic properties of soluble shigella antigens].
    Gorbunova ES; Stepanova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):58-63. PubMed ID: 335736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp.
    Adamus G; Mulczyk M; Witkowska D; Romanowska E
    Infect Immun; 1980 Nov; 30(2):321-4. PubMed ID: 7002794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The protective properties of the endotoxin protein].
    Levenson VI; Belkin ZP; Egorova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):5-9. PubMed ID: 1950285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ribosomal dysentery vaccine. II. Biological trials of active protection for guinea pigs and mice].
    Levinson VI; Subbotina IuL
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):81-6. PubMed ID: 358702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
    Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
    [No Abstract]   [Full Text] [Related]  

  • 13. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. II. HISTOLOGIC FINDINGS.
    LIN FC; YANG TL; WU PF
    Chin Med J; 1964 Jul; 83():463-9. PubMed ID: 14191219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Local immunity in the parenteral immunization of guinea pigs with a ribosomal dysentery vaccine].
    Liubinskaia MM; Rukhadze EZ; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):55-9. PubMed ID: 3901625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific disappearance of macrophages from the peritoneal exudate of guinea pigs following administration of Sh. sonnei endotoxin].
    Solov'eva OG; Korneeva SA
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):62-6. PubMed ID: 6994415
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
    Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenic properties of the toxic constituents of Shigella dysenteriae type 1].
    Meitert T; Istrati G; Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1968 Dec; 27(4):793-802. PubMed ID: 4912627
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problem of specific prevention of dysentery. I. Selection of avirulent immunogenic strains of Flexner and Sonne dysentery bacteria].
    Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):14-9. PubMed ID: 4898256
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of the immunogenicity of neurotoxin preparations and their separate fractions obtained from Shigella sonnei, phases I and II].
    Kamzolkina NB; Iarovaia LM
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):23-6. PubMed ID: 6367318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants].
    Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.